1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 7:Demographic summary of the patients with black turbinatesa
Total Female Male P (M vs F) Pediatric Patients Adult Patients P (Adult vs Pediatric) FS group 16 11 (69%) 5 (31%) .28b 2 (12%) (11 and 14 yr) 14 (88%) (range, 31–74 yr) .73b Brain group 29 17 (59%) 12 (41%) .83b 1 (3%) (10 yr) 28 (97%) (range, 24–79 yr) .02b,c P FS vs brain .54d .28d
↵a All P values were calculated using the Fisher exact test.
↵b To compare the sex and age compositions of each BT group with the general population, assuming even sex distribution and approximately 24% pediatric population.
c Significant.
↵d To compare the sex and age composition between the FS and brain BT groups.